JPRN-jRCT1080224042已完成2 期
A randomized, double-blind, placebo-controlled clinical study of CL2020 in ischemic stroke patient
ife Science Institute, Inc0 个研究点目标入组 35 人开始时间: 2018年9月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
A single intravenous dose of CL2020 was administered to subjects with cerebral infarction, and they were observed until Week 52. No major safety problems were observed. The results of efficacy endpoints suggested the efficacy of CL2020 in patients with cerebral infarction.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •[Major inclusion criteria]
- •1) Patients who can be registered between 14 and 28 days after onset of ischemic stroke
- •2) Patients who have moderate-to-severe neurological deficits, e.g., physical disabilities
- •3) Patients must have a score of the National Institutes of Health Stroke Scale of 6 or higher at registration.
排除标准
- •[Major exclusion criteria]
- •1) Severe consciousness disturbance
- •2) Hemorrhagic transformation assessed by CT or MRI
研究者
相似试验
终止
2 期
Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)Covid19NCT04900428Sorrento Therapeutics, Inc.179
已完成
2 期
Trial of inhaled anti-viral (SNG001) for SARS-CoV-2 (COVID-19) infectioCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN14241621Synairgen Research Ltd220
终止
2 期
Phase IIa Clinical Study of N-Rephasin® SAL200Staphylococcus Aureus BacteremiaAnti-Bacterial AgentsNCT03089697Intron Biotechnology, Inc.25
已完成
2 期
Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy SurgeryAcute PainNCT00877799Cara Therapeutics, Inc.114
已完成
不适用
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily SerumWrinklePhotoagingNCT05514782Revision Skincare67